HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Transcriptional profiles in liver from mice treated with hepatotumorigenic and nonhepatotumorigenic triazole conazole fungicides: Propiconazole, triadimefon, and myclobutanil.

Abstract
Conazoles are environmental and pharmaceutical fungicides. The present study relates the toxicological effects of conazoles to alterations of gene and pathway transcription and identifies potential modes of tumorigenic action. In a companion study employing conventional toxicological bioassays (Allen et al., 2006), male CD-1 mice were fed triadimefon, propiconazole, or myclobutanil in a continuous oral-dose regimen for 4, 30, or 90 days. These conazoles were found to induce hepatomegaly, to induce high levels of hepatic pentoxyresorufin-O-dealkylase activity, to increase hepatic cell proliferation, to decrease serum cholesterol, and to increase serum triglycerides. Differentially expressed genes and pathways were identified using Affymetrix GeneChips. Gene-pathway associations were obtained from the Kyoto Encyclopedia of Genes and Genomes, Biocarta, and MetaCore compendia. The pathway profiles of each conazole were different at each time point. In general, the number of altered metabolism, signaling, and growth pathways increased with time and dose and were greatest with propiconazole. All conazoles had effects on nuclear receptors as evidenced by increased expression and enzymatic activities of a series of related cytochrome P450s (CYP). A subset of altered genes and pathways distinguished the three conazoles from each other. Triadimefon and propiconazole both altered apoptosis, cell cycle, adherens junction, calcium signaling, and EGFR signaling pathways. Triadimefon produced greater changes in cholesterol biosynthesis and retinoic acid metabolism genes and in selected signaling pathways. Propiconazole had greater effects on genes responding to oxidative stress and on the IGF/P13K/AKt/PTEN/mTor and Wnt-beta-catenin pathways. In conclusion, while triadimefon, propiconazole, and myclobutanil had similar effects in mouse liver on hepatomegaly, histology, CYP activities, cell proliferation, and serum cholesterol, genomic analyses revealed major differences in their gene expression profiles.
AuthorsWilliam O Ward, Don A Delker, Susan D Hester, Sheau-Fung Thai, Douglas C Wolf, James W Allen, Stephen Nesnow
JournalToxicologic pathology (Toxicol Pathol) Vol. 34 Issue 7 Pg. 863-78 ( 2006) ISSN: 0192-6233 [Print] United States
PMID17178688 (Publication Type: Journal Article)
Chemical References
  • Fungicides, Industrial
  • Nitriles
  • Reactive Oxygen Species
  • Receptors, Cytoplasmic and Nuclear
  • Triazoles
  • propiconazole
  • triadimefon
  • RNA
  • Cholesterol
  • systhane
Topics
  • Animals
  • Biological Assay
  • Cholesterol (biosynthesis)
  • Data Interpretation, Statistical
  • Dose-Response Relationship, Drug
  • Fungicides, Industrial (toxicity)
  • Gene Expression Regulation, Neoplastic (drug effects)
  • Liver (drug effects, enzymology, metabolism)
  • Liver Neoplasms, Experimental (chemically induced, genetics)
  • Male
  • Mice
  • Nitriles (toxicity)
  • Oligonucleotide Array Sequence Analysis
  • Principal Component Analysis
  • RNA (biosynthesis, isolation & purification)
  • Reactive Oxygen Species (metabolism)
  • Receptors, Cytoplasmic and Nuclear (drug effects, metabolism)
  • Signal Transduction (drug effects)
  • Transcription, Genetic (drug effects)
  • Triazoles (toxicity)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: